Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.

Ryan CJ, Zavodovskaya M, Youngren JF, Campbell M, Diamond M, Jones J, Shiry L, Allan G, Maddux BA, Goldfine ID.

Prostate. 2008 Aug 1;68(11):1232-40. doi: 10.1002/pros.20789.

PMID:
18491370
[PubMed - indexed for MEDLINE]
2.

Interaction of IGF signaling and the androgen receptor in prostate cancer progression.

Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.

J Cell Biochem. 2006 Oct 1;99(2):392-401. Review.

PMID:
16639715
[PubMed - indexed for MEDLINE]
3.

Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.

Ozkan EE.

Mol Cell Endocrinol. 2011 Sep 15;344(1-2):1-24. doi: 10.1016/j.mce.2011.07.002. Epub 2011 Jul 18. Review.

PMID:
21782884
[PubMed - indexed for MEDLINE]
4.

Mechanisms of prostate cancer cell survival after inhibition of AR expression.

Cohen MB, Rokhlin OW.

J Cell Biochem. 2009 Feb 15;106(3):363-71. doi: 10.1002/jcb.22022. Review.

PMID:
19115258
[PubMed - indexed for MEDLINE]
5.

Structure and function of the type 1 insulin-like growth factor receptor.

Adams TE, Epa VC, Garrett TP, Ward CW.

Cell Mol Life Sci. 2000 Jul;57(7):1050-93. Review.

PMID:
10961344
[PubMed - indexed for MEDLINE]
6.

The androgen receptor mRNA.

Yeap BB, Wilce JA, Leedman PJ.

Bioessays. 2004 Jun;26(6):672-82. Review.

PMID:
15170865
[PubMed - indexed for MEDLINE]
7.

Expression and function of androgen receptor in carcinoma of the prostate.

Culig Z, Hobisch A, Bartsch G, Klocker H.

Microsc Res Tech. 2000 Dec 1;51(5):447-55. Review.

PMID:
11074615
[PubMed - indexed for MEDLINE]
8.

Human prostate cancer: a direct role for oestrogens.

Castagnetta LA, Carruba G.

Ciba Found Symp. 1995;191:269-86; discussion 286-9. Review.

PMID:
8582203
[PubMed - indexed for MEDLINE]
9.

Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine.

Hewish M, Chau I, Cunningham D.

Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):54-72. Review.

PMID:
19149688
[PubMed - indexed for MEDLINE]
10.

IGF-1 and prostate cancer.

Roberts CT Jr.

Novartis Found Symp. 2004;262:193-9; discussion 199-204, 265-8. Review.

PMID:
15562830
[PubMed - indexed for MEDLINE]
11.

The IGF receptor as anticancer treatment target.

Macaulay VM.

Novartis Found Symp. 2004;262:235-43; discussion 243-6, 265-8. Review.

PMID:
15562833
[PubMed - indexed for MEDLINE]
12.

[Anti-apoptotic effect of the androgen receptor in human prostate cancer].

Shen FY, Li BY.

Zhonghua Nan Ke Xue. 2007 Dec;13(12):1121-4. Review. Chinese.

PMID:
18284065
[PubMed - indexed for MEDLINE]
13.

Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms.

Schröder FH.

Eur Urol. 2008 Jun;53(6):1129-37. doi: 10.1016/j.eururo.2008.01.049. Epub 2008 Jan 28. Review.

PMID:
18262723
[PubMed - indexed for MEDLINE]
14.

[Molecular targeted therapy for prostate cancer].

Hashimoto Y, Naruyama H, Ando R, Okada S, Tozawa K, Kohri K.

Hinyokika Kiyo. 2008 Jan;54(1):57-61. Review. Japanese.

PMID:
18260363
[PubMed - indexed for MEDLINE]
Free Article
15.

PA-III rat prostate adenocarcinoma cells (review).

Koutsilieris M.

In Vivo. 1992 Mar-Apr;6(2):199-203. Review.

PMID:
1326342
[PubMed - indexed for MEDLINE]
16.

The IGF-1 receptor and its contributions to metastatic tumor growth-novel approaches to the inhibition of IGF-1R function.

Bähr C, Groner B.

Growth Factors. 2005 Mar;23(1):1-14. Review.

PMID:
16019422
[PubMed - indexed for MEDLINE]
17.

The complex biology of the receptor for the insulin-like growth factor-1.

Romano G.

Drug News Perspect. 2003 Oct;16(8):525-31. Review.

PMID:
14668950
[PubMed - indexed for MEDLINE]
18.

Androgen action in the epididymis.

Robaire B, Hamzeh M.

J Androl. 2011 Nov-Dec;32(6):592-9. doi: 10.2164/jandrol.111.014266. Epub 2011 Jul 15. Review.

PMID:
21764895
[PubMed - indexed for MEDLINE]
Free Article
19.

Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.

Thomas LN, Douglas RC, Lazier CB, Too CK, Rittmaster RS, Tindall DJ.

Eur Urol. 2008 Feb;53(2):244-52. Epub 2007 Nov 5. Review.

PMID:
18006217
[PubMed - indexed for MEDLINE]
20.

The IGF axis in prostate cancer.

Monti S, Proietti-Pannunzi L, Sciarra A, Lolli F, Falasca P, Poggi M, Celi FS, Toscano V.

Curr Pharm Des. 2007;13(7):719-27. Review.

PMID:
17346186
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk